XTRA:BAYNPharmaceuticals
Is Bayer (XTRA:BAYN) Still Attractively Priced After Addressing Legacy Issues?
If you are wondering whether Bayer's share price still reflects its underlying worth after a strong run, you are not alone.
The stock recently closed at €44.82, with returns of 1.8% over the last 7 days, 17.8% over 30 days, 17.9% year to date and 112.2% over the past year, set against 3 year and 5 year returns of 22.1% decline and 6.5% decline respectively.
Recent news coverage has focused on Bayer's ongoing efforts to address its legacy issues and reposition its pharmaceutical and crop...